V.A.C. Therapy System Fact Sheet
The KCI proprietary V.A.C.® Therapy System has revolutionised the way in which carers treat the most serious, complex wounds. V.A.C. Therapy uses an open-cell polymer foam dressing that is conformed to the wound bed. When sealed and placed under negative (vacuum) pressure, the system creates a unique wound healing environment that has been shown to promote the wound healing process, reduce oedema, prepare the wound bed for closure, promote the formation of granulation tissue and remove infectious materials.
Mechanisms of Action close up
3 McNulty A, Schmidt M, Feeley T, Kieswetter K. Effects of negative pressure wound therapy on fibroblast viability, chemotactic signaling, and proliferation in a provisional wound (fibrin) matrix. Wound Repair and Regeneration 2007; 15(6): 838-846.
In 1996, KCI introduced this innovative approach to the treatment of serious, complex wounds through the use of sub-atmospheric or negative pressure. Known today as “negative pressure wound therapy” (NPWT), KCI’s proprietary Vacuum Assisted Closure®, or V.A.C.® Therapy System has revolutionised the advanced wound care market and today remains the most clinically proven alternative for the treatment of complex, hard-to-heal wounds.
The InfoV.A.C.® System is a wound healing therapy system designed for patients in the acute care setting.
The ActiV.A.C.® System is designed for ambulatory patients and is used primarily in the home care setting.
The ABThera™ Open Abdomen Negative Pressure Therapy System addresses patient quality of life through an easy-to-use system designed to assist surgeons in the management and treatment of “open abdomen” and to help achieve primary fascial closure.
Research and Development (R&D)
KCI continues to invest in innovation with an ongoing commitment to research and development aimed at improving patient outcomes while reducing the overall cost of care. In 2008, KCI invested more than $76 million in its R&D efforts, which are led by approximately 240 clinical research and development professionals.
V.A.C.® Therapy is recognised as a significant, clinically proven advancement in wound care that promotes active wound healing at the cellular level using three vital V.A.C. Therapy components:
- The proprietary V.A.C.® GranuFoam™ Dressing means the difference between healing and simply draining a wound. GranuFoam Dressings provide increased metabolic activity and evenly distributes vacuum pressure at the wound surface, creating the angiogenesis and cell proliferation necessary for wound healing. Gauze-based negative pressure wound therapy devices only drain the wound. The technology of GranuFoam Dressings also allows the dressing to adapt to the contours of deep or unevenly shaped wounds.
- The technology of SensaT.R.A.C.™ Dressings regulates pressure at the wound site to ensure patients receive the prescribed amount of negative pressure for optimal healing.
- The V.A.C.® Therapy unit uses sophisticated software algorithms to provide intermittent and continuous negative pressure to the wound.
V.A.C. Therapy at a Glance
|Wounds Treated||8 million worldwide*|
|Usage Growth Rate||486 percent by prescribing physicians|
|Key Relationships Globally||
21,000 hospitals and skilled nursing facilities
11,000 home health agencies
|Caregivers Trained (Continuing Education)||Accredited training for caregivers in all care settings|
1,000+ member clinical sales team
24x7x365 Customer and Patient Support
*As of 12/31/13 KCI data on file
Clinical Study Support
KCI’s V.A.C. Therapy System enjoys an unprecedented body of clinical evidence that demonstrates clinical efficacy and cost-effectiveness, with:
- 41 Randomised Controlled Trials (RCTs)
- More than 918 Peer Reviewed Articles
- More than 931 Abstracts
- 71 Medical Text Book Citations
For more information, contact:
Kinetic Concepts, Inc.
Media@kci1.com for journalists only.
This Web page contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use.
Updated: 12 May 2014